EGFR and adenocarcinoma: In the EGFR‐positive group, the majority were female (χ2 = 61.934, P < 0.001), non‐smoking (χ2 = 59.315, P < 0.001), and adenocarcinoma (χ2 = 44.864, P < 0.001) patients.